Short interest in UroGen Pharma Ltd (NASDAQ:URGN) increased during the last reporting period, rising from 6.49M to 6.60M. This put 16.04% of the company's publicly available shares short.

Short interest for UroGen Pharma gives investors a sense of the degree to which investors are betting on the decline of UroGen Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 614.52K shares traded per day, it would take 10.74 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.